News
According to the latest study from BCC Research, the "Cancer Immunotherapy: Technologies and Global Markets" is expected to ...
Liver cancer is the sixth most common cancer worldwide and the third leading cause of cancer mortality. In Hong Kong, it ranks fifth in annual cancer incidence and third in mortality.
Shoaib Ibrahim shared a new vlog sharing details about wife Dipika Kakar’s on-going treatment and their recent meeting with ...
Dipika Kakar was diagnosed with Stage 2 liver cancer in May, days after she complained of a stomach ache. The surgery was ...
4hon MSN
Danielle Walker, 36, plans to undergo immunotherapy treatment in Germany which costs £35,000 a course :: The family has ...
In a remarkable stride for cancer treatment, Kauvery Cancer Institute- Kauvery Hospital, Alwarpet, has successfully performed ...
Dipika Kakar and Shoaib Ibrahim marked one month since her liver cancer surgery with a heartfelt health update. As she moves ...
Hepatocellular carcinoma (HCC), the most common type of liver cancer and the third-leading cause of cancer-related deaths ...
Shoaib Ibrahim said Dipika Kakar has no cancer cells, but since the tumour was classified as "grade three and poorly ...
2d
India Today on MSNShoaib Ibrahim says Dipika Kakar's cancer can recur, treatment may take 2 yearsActor Shoaib Ibrahim recently revealed that his wife Dipika Kakar's cancer can recur after surgery. He even updated fans about her medication and further treatment.
In vivo CAR T cell generation is a pioneering immunotherapy approach that reprograms the immune system to fight cancer and ...
The European Commission has cleared OD-L1 inhibitor Imfinzi (durvalumab) to treat adults with resectable muscle-invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results